DHR - Danaher Corporation
NYSE
->
Healthcare
->
Diagnostics & Research
Washington,
United States
Type: Equity
DHR price evolution
DHR
| (in millions $) | 27 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2374 | $7031 | $5864 | |
| Short term investments | ||||
| Net receivables | $4097 | $3298 | $3379 | $3922 |
| Inventory | $2678 | $2671 | $2645 | $2594 |
| Total current assets | $10060 | $9609 | $14372 | $13937 |
| Long term investments | ||||
| Property, plant & equipment | $6043 | $4643 | $4562 | $4553 |
| Goodwill & intangible assets | $60350 | $60734 | $62354 | |
| Total noncurrent assets | $68946 | $69030 | $70551 | |
| Total investments | ||||
| Total assets | $80615 | $78555 | $83402 | $84488 |
| Current liabilities | ||||
| Accounts payable | $1596 | $1645 | $1679 | $1766 |
| Deferred revenue | ||||
| Short long term debt | $701 | $1746 | $1695 | |
| Total current liabilities | $7339 | $6701 | $7778 | $8274 |
| Long term debt | $16324 | $16309 | $16417 | $16707 |
| Total noncurrent liabilities | $21952 | $22177 | $22724 | |
| Total debt | $17010 | $18163 | $18402 | |
| Total liabilities | $29316 | $28653 | $29955 | $31002 |
| Shareholders' equity | ||||
| Retained earnings | $43296 | $42673 | $41962 | $41074 |
| Other shareholder equity | -$1310 | -$2591 | -$2744 | -$1748 |
| Total shareholder equity | $49897 | $53442 | $53486 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $5864 | $5995 | $2586 | $6035 |
| Short term investments | ||||
| Net receivables | $3922 | $4918 | $4631 | $4045 |
| Inventory | $2594 | $3110 | $2767 | $2292 |
| Total current assets | $13937 | $15883 | $11648 | $13802 |
| Long term investments | $27 | |||
| Property, plant & equipment | $4553 | $3956 | $3790 | $3262 |
| Goodwill & intangible assets | $62354 | $60052 | $64027 | $56702 |
| Total noncurrent assets | $70551 | $68467 | $71536 | $62359 |
| Total investments | ||||
| Total assets | $84488 | $84350 | $83184 | $76161 |
| Current liabilities | ||||
| Accounts payable | $1766 | $2296 | $2569 | $2049 |
| Deferred revenue | ||||
| Short long term debt | $1695 | $591 | $8 | $11 |
| Total current liabilities | $8274 | $8389 | $8140 | $7402 |
| Long term debt | $16707 | $19086 | $22168 | $21193 |
| Total noncurrent liabilities | $22724 | $25871 | $29867 | $28982 |
| Total debt | $18402 | $19677 | $22176 | $21204 |
| Total liabilities | $31002 | $34268 | $38007 | $36384 |
| Shareholders' equity | ||||
| Retained earnings | $41074 | $39205 | $32827 | $27159 |
| Other shareholder equity | -$1748 | -$2872 | -$1027 | -$368 |
| Total shareholder equity | $53486 | $50082 | $45167 | $39766 |
| (in millions $) | 27 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $5798 | $5743 | $5796 | $6405 |
| Cost of revenue | $2315 | $2309 | ||
| Gross Profit | $3401 | $3428 | $3487 | $3779 |
| Operating activities | ||||
| Research & development | $391 | $368 | ||
| Selling, general & administrative | $1869 | $1807 | ||
| Total operating expenses | $2221 | $2260 | $2175 | $2442 |
| Operating income | $1168 | $1312 | ||
| Income from continuing operations | ||||
| EBIT | $1148 | $1336 | ||
| Income tax expense | $159 | $176 | $183 | $111 |
| Interest expense | $20 | $65 | $65 | $32 |
| Net income | ||||
| Net income | $818 | $907 | $1088 | $1079 |
| Income (for common shares) | $907 | $1088 | ||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $23890 | $31471 | $22284 | |
| Cost of revenue | $12522 | $9809 | ||
| Gross Profit | $14034 | $18949 | $12475 | |
| Operating activities | ||||
| Research & development | $1745 | $1348 | ||
| Selling, general & administrative | $8516 | $6896 | ||
| Total operating expenses | $8832 | $10261 | $8244 | |
| Operating income | $8688 | $4231 | ||
| Income from continuing operations | ||||
| EBIT | $8503 | $4770 | ||
| Income tax expense | $823 | $1083 | $849 | |
| Interest expense | $17 | $211 | $275 | |
| Net income | ||||
| Net income | $4743 | $7209 | $3646 | |
| Income (for common shares) | $7103 | $3510 | ||
| (in millions $) | 27 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | $907 | $1088 | ||
| Operating activities | ||||
| Depreciation | $580 | $586 | ||
| Business acquisitions & disposals | -$12 | |||
| Stock-based compensation | $87 | $60 | ||
| Total cash flows from operations | $1417 | $1739 | ||
| Investing activities | ||||
| Capital expenditures | -$286 | -$291 | ||
| Investments | -$74 | -$44 | ||
| Total cash flows from investing | -$1287 | -$360 | -$321 | -$7081 |
| Financing activities | ||||
| Dividends paid | -$573 | -$200 | -$177 | -$821 |
| Sale and purchase of stock | -$4453 | -$1 | ||
| Net borrowings | -$1027 | $68 | ||
| Total cash flows from financing | -$6693 | -$5715 | -$133 | -$273 |
| Effect of exchange rate | $74 | $1 | -$118 | $59 |
| Change in cash and equivalents | -$3237 | -$4657 | $1167 | -$131 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $7209 | $6433 | $3646 | |
| Operating activities | ||||
| Depreciation | $2222 | $2168 | $1775 | |
| Business acquisitions & disposals | -$637 | -$10935 | -$20145 | |
| Stock-based compensation | $336 | $218 | $187 | |
| Total cash flows from operations | $8519 | $8358 | $6208 | |
| Investing activities | ||||
| Capital expenditures | -$1143 | -$1281 | -$789 | |
| Investments | -$505 | -$808 | -$329 | |
| Total cash flows from investing | -$7081 | -$2234 | -$12987 | -$21239 |
| Financing activities | ||||
| Dividends paid | -$821 | -$818 | -$742 | -$615 |
| Sale and purchase of stock | $31 | $86 | $1882 | |
| Net borrowings | -$1688 | $1967 | -$1926 | |
| Total cash flows from financing | -$273 | -$2570 | $1295 | $1006 |
| Effect of exchange rate | $59 | -$306 | -$115 | $148 |
| Change in cash and equivalents | -$131 | $3409 | -$3449 | -$13877 |
News
Fundamentals
| Market cap | $142.92B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 722.20M |
| Revenue | $23.74B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $3.89B |
| Revenue Q/Q | -15.64% |
| Revenue Y/Y | -19.70% |
| P/E ratio | 36.72 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 6.02 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $5.39 |
|---|---|
| ROA | 4.76% |
| ROE | N/A |
| Debt/Equity | 0.58 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.37 |
| Quick ratio | 1.01 |